Overview of the miR-29 family members' function in breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRs) are crucial regulators in human cancers, influencing multiple signaling pathways and gene expression.
• The miR-29 family's role in breast cancer (BC) is complex and context-dependent, with evidence supporting both tumor-suppressive and pro-metastatic functions.

Purpose of the Study:

• To review and synthesize current knowledge on the miR-29 family's multifaceted roles in breast cancer.
• To explore how miR-29 dysregulation impacts BC initiation, progression, invasion, and therapy resistance across different subtypes.

Main Methods:

• Literature review and synthesis of existing research on miR-29 in breast cancer.
• Analysis of signaling pathways and gene targets modulated by miR-29 in BC.
• Examination of the influence of long non-coding RNAs on miR-29 expression in BC.

Main Results:

• miR-29 acts as a tumor suppressor by targeting pathways like TIMP3/STAT1/FOXO1 and EZH2-miR-29b/miR-30d-LOXL4, inhibiting proliferation and metastasis.
• Conversely, elevated miR-29 in some BC cases promotes migration and metastasis by targeting genes such as tristetraprolin and N-myc interactor.
• miR-29 family members exhibit diverse regulatory roles influenced by cellular environment and signaling context.

Conclusions:

• The dual role of miR-29 in breast cancer necessitates further investigation into its specific functions in different BC subtypes and contexts.
• Understanding miR-29's complex regulatory network is vital for developing targeted BC therapies.
• Long non-coding RNAs represent an additional layer of regulation influencing miR-29's impact on breast cancer progression.